TB expert joins Oxford Immunotec

Oxford Immunotec, a T-cell measurement company, announced on Wednesday that it has appointed Michael D. Iseman as its senior scientific advisor.

Iseman is a world-renowned pulmonologist and a leading authority on tuberculosis disease. Iseman will provide the company and healthcare professionals with guidance in the company’s efforts to improve the diagnosis of TB infection and to eradicate the disease in the United States.

“Improving the diagnosis of TB infection is critically important, and Dr. Iseman is uniquely qualified to help us in our goal to set the standard for TB testing accuracy, simplicity and cost-effectiveness,” Jeff Schroeder, president of Oxford Immunotec, Inc., said. “In addition, Dr. Iseman’s highly-regarded ability to educate medical professionals will be invaluable in raising awareness of the differences between innovative technology like our T-SPOT®.TB test and the 100 year-old tuberculin skin test.”

Tuberculosis is a common and frequently deadly infection caused by Mycobacterium tuberculosis. It spreads through the air when those with active tuberculosis cough or sneeze. While most infections in humans lead to asymptomatic, latent TB, approximately one in 10 latent infections progress to active disease. The disease attacks the lungs but can also affect other parts of the body.

Iseman has been a consultant to the Centers for Disease Control and Prevention and the World Health Organization. He has authored many editorials and articles on TB, including the textbook “A Clinician’s Guide to Tuberculosis.”

In the United States, it is estimated that 14 million people have latent TB infections. The CDC reported over 11,000 active cases of TB in 2010.